Home Blog Page 32

Young Choi Named StarKist President & CEO: Leading the Future of Seafood Excellence

0

In a significant move marking a new chapter in its storied history, StarKist Co. is proud to announce the appointment of Mr. Young Choi as its new President and CEO. This strategic decision, effective immediately, recognizes Mr. Choi’s invaluable contributions and exceptional leadership skills demonstrated in his previous roles within the company.

From Finance Expert to Corporate Leader: Young Choi’s Journey

Before his remarkable ascent to the top position, Mr. Choi has been instrumental in shaping the financial and operational strategies of StarKist. Since joining the company in May 2022, he has served with distinction as the Vice President of Finance, Chief Operating Officer (COO), and Chief Financial Officer (CFO). His expertise and vision have been pivotal in steering the company through dynamic market conditions.

A Rich Tapestry of Global Experience

Mr. Choi’s professional journey is marked by diverse and extensive experience in the finance sector. Prior to joining StarKist, he held various executive positions in finance at SPC Group and Tesco, spanning across the United States, the United Kingdom, and South Korea. His tenure at these organizations, from December 2007 to April 2022, has endowed him with a global perspective and deep insights into the financial workings of major corporations.

From 1998 to November 2007, Mr. Choi honed his skills as a certified public accountant at Deloitte, gaining experience in both South Korea and the United States. His academic credentials are equally impressive, holding a Bachelor’s degree from Yonsei University in South Korea and an MBA from Manchester Business School in the United Kingdom.

A Fond Farewell to Chae-Ung Um

As we welcome Mr. Choi, StarKist also extends its heartfelt gratitude to Mr. Chae-Ung Um, the outgoing President & CEO. Mr. Um’s leadership and contributions have been invaluable, and we wish him the best in his future endeavors.

Looking Ahead: StarKist’s Commitment Under Choi’s Leadership

Under Mr. Choi’s leadership, StarKist remains steadfast in its commitment to delivering the highest quality protein products to its consumers. The company looks forward to a seamless transition and a future marked by innovation, sustainability, and continued excellence in the seafood industry.

StarKist is poised for an exciting future with Young Choi at the helm. His blend of financial acumen, global experience, and visionary leadership is set to propel the company to new heights in the seafood industry. Stay tuned for more updates as we embark on this thrilling journey under Mr. Choi’s guidance.

Bill C-368: A Conservative Effort to Safeguard Canada’s Natural Health Products Market

0

In a significant move, Blaine Calkins, the Conservative Member of Parliament for Red Deer-Lacombe, has introduced Bill C-368, An Act to amend the Food and Drugs Act, focusing on natural health products. This legislative initiative emerges as a direct response to the Liberal government’s Bill C-47, which has stirred considerable debate over the regulation of natural health products in Canada.

Understanding the Impact of Bill C-47

Bill C-47, introduced by the Liberal government, has been a subject of contention, primarily due to its approach to regulating natural health supplements. The bill equates these supplements with therapeutic synthetic drugs, introducing a new set of regulations that could significantly impact the industry. These include substantial fees for the importation, manufacturing, and sale of natural health products, as well as stringent new labelling laws.

The Conservative Response: Bill C-368

In reaction to these developments, MP Calkins has put forward Bill C-368. This bill aims to repeal sections 500 to 504 of Bill C-47, which Calkins and his supporters view as an overreach of governmental power. “The Liberals’ Bill C-47 is poised to dramatically disrupt the market and represents a direct attack on Canadian consumers and small businesses,” MP Calkins stated. His bill seeks to dismantle what he describes as “unnecessary and restrictive red tape,” aiming to restore the natural health products’ status in Canada.

The Stakes for Canadian Businesses and Consumers

The implications of the current regulatory changes are significant. An alarming 70% of brands have indicated potential product withdrawal from the market, and about 20% are considering exiting the Canadian market altogether. These figures highlight the potential disruption to both the industry and consumers who rely on these products. MP Calkins emphasized, “In their usual out-of-touch manner, Liberals introduced changes that are not just bureaucratic red tape, they are chains that bind the hands of our entrepreneurs, stifling innovation and limiting consumer choice.”

The Way Forward

Bill C-368 represents a critical stance against what the Conservatives perceive as governmental overreach. It underscores a commitment to protecting the rights of Canadians to make their own health choices. “Common sense Conservatives will push back against this governmental overreach and protect the fundamental rights of Canadians to make their own health choices, free from undue interference from Ottawa,” concluded MP Calkins.

As this legislative battle unfolds, it will be crucial to monitor how these developments impact the natural health products industry, consumer choices, and the broader regulatory landscape in Canada.

Why does Pycnogenol® offer such a wide range of health benefits? Its mechanisms of action explained

0

Pycnogenol® French maritime pine bark is dubbed the “gold standard ingredient”, “a phenomenon” and a “natural all-rounder” (1, 2). Clinical studies have shown Pycnogenol® to be beneficial for heart health, cognitive function and respiratory health, as well as for eye health, skincare, women’s health and several other body functions (3-10). But how can one ingredient alone have such a wide range of benefits across multiple applications? Let’s shed some light on the holistic nature and efficacy of Pycnogenol®.

Pycnogenol® is much more than just an ingredient

First and foremost, Pycnogenol® stands apart from single compounds. Pycnogenol® is a naturally programmed combination of procyanidins, bioflavonoids and organic acids, which offer amazing properties. Pycnogenol®‘s unique blend of active compounds cannot be found in any other plant extract. Each of its compounds provides a different way of acting in the body. Some of the larger molecules get further processed in the gut into metabolites. Remarkably, these metabolites are also absorbed into our bloodstream, contributing to Pycnogenol®‘s overall efficacy.

Consequently, Pycnogenol® offers a comprehensive array of active compounds, distinguishing it from single-component alternatives. The key properties of Pycnogenol® on the body are its powerful antioxidant actions (3, 4, 11-16), its natural anti-inflammatory benefits (17-19), its effects on skin and tissues (8, 18, 20, 21) and its support for blood circulation (3, 7, 22-33).

Collectively, these mechanisms account for the extensive range of applications that Pycnogenol® holds in the realms of health and beauty. Ongoing research will continue to unveil further insights and potentially discover additional applications for the effects of Pycnogenol®.

Pycnogenol® improves blood circulation

Keeping the cardiovascular system healthy is key for maintaining good vitality, physical strength and for general well-being. Blood vessels bring oxygen and nutrients through arteries and small microvessels all over our body, providing beneficial effects from head to toe.

Pycnogenol® exerts some of its beneficial effects as it optimizes blood flow by improving endothelial function. Blood flow regulation involves maintaining an appropriate distribution of blood throughout the body to meet the metabolic demands of tissues and organs.

All blood vessels in the cardiovascular system are lined with the so-called endothelium. The endothelium is a single layer of cells lining the inner surface of blood vessels, including arteries and veins. This layer is significantly involved in many physiological functions, like controlling blood pressure by vasoconstriction and -dilation, regulating the exchange of substances between blood and tissues, preventing blood clotting, and signaling during inflammation. Endothelial function and blood flow regulation are crucial for overall health.

Many different studies have shown that Pycnogenol® has a positive effect on blood circulation and microcirculation (7, 28-31, 34-37) by improving endothelial function (3, 22-27) and by lowering platelet aggregation without increasing bleeding time (32, 33). In addition, Pycnogenol® has been shown to normalize blood pressure and to improve blood lipid profile as well as blood sugar values (12, 13, 15, 25, 26, 38-43). Interestingly, it was found that a metabolite of Pycnogenol® can be taken up in endothelial cells and can thus exert its anti-inflammatory effects directly in the endothelium (24).

Pycnogenol® for the endothelium

Numerous studies have consistently shown that Pycnogenol® improves endothelial function, resulting in a positive impact on both blood circulation and microcirculation.

In patients with coronary artery disease, the effect of Pycnogenol® on endothelial function was investigated by assessing “flow-mediated dilation” in the upper arm artery (3). For this, the expansion of the artery in response to an increase in the shear stress associated with blood flow is measured. An 8-week randomized, placebo-controlled, crossover, double-blind study showed an improvement in flow-mediated dilation by 32% in the Pycnogenol® group, while it deteriorated slightly in the placebo patients.

Pycnogenol® improves microcirculation

Healthy microcirculation is vital as it leads to a well-functioning supply of nutrients and oxygen to all parts of the body. In several studies, Pycnogenol® was shown to improve blood circulation in small blood vessels in the body, like the fine microvessels in skin, fingertips and in the inner ear or the retinal capillaries in the eye (7, 28-31, 34-37).

Pycnogenol® helps break the cycle of inflammation and oxidative stress naturally

The anti-inflammatory and antioxidant properties of Pycnogenol® further contribute to the versatile nature of Pycnogenol® on body health and beauty. Inflammation and oxidative stress are closely linked processes in the body. Oxidative stress can trigger inflammation, which in turn can lead to more oxidative stress. (44). Initially, inflammation is a complex protective response of the body to harmful stimuli and is part of innate immunity. However, too much inflammation can lead to chronic inflammation – the basis of various diseases such as atherosclerosis, arthritis or allergies.

Pycnogenol® controls inflammation

In several studies, it was shown that Pycnogenol® has inflammation-reducing properties (17-19). Pycnogenol® was shown to significantly limit the activation of pro-inflammatory «master switch» NF-kB by 15.5% and matrix metalloproteinase 9 (MMP-9) release by 25% (18) – two important regulators in the inflammation process. In another study, Pycnogenol® prevented the up-regulation of the pro-inflammatory enzymes 5-LOX and COX-2, also providing a significant contribution for lowering pain (17).

These beneficial effects of Pycnogenol® were also observed in clinical studies with patients, suffering from different chronic inflammatory conditions like knee osteoarthritis (45, 46), endometriosis (47, 48) or allergic rhinitis (6, 49). Pycnogenol® was shown to promote joint mobility and flexibility and naturally relieve pain.

Pycnogenol® is a powerful antioxidant

Pycnogenol® has been investigated in various clinical studies and shown to possess potent antioxidant properties (3, 4, 11-16). Pycnogenol® has been shown to both increase plasma antioxidant capacity (“oxygen radical absorbance capacity”, ORAC) (13) and decrease plasma oxidative stress measured as plasma free radicals (50). Pycnogenol® has further been shown to protect lipids from peroxidation by free radicals (3, 4). The protective effect of Pycnogenol® on DNA oxidation was shown in another clinical study (11).

Pycnogenol® strengthens the extracellular matrix in skin, joints and other tissues

The extracellular matrix plays a vital role in various connective tissues, functioning as a supportive framework, regulates cell behavior, and influences tissue development and repair. The skin’s extracellular matrix consists of different molecules like collagen, elastin and hyaluronic acid. Collagen provides structural support and firmness to the skin, while elastin ensures its elasticity. Hyaluronic acid contributes to skin hydration by retaining moisture. These molecules collectively promote youthful, healthy skin and can help address issues related to skin aging processes.

In addition, collagen is a significant component of cartilage, which covers and protects the ends of bones in joints. It contributes to joint stability and flexibility. Hyaluronic acid is also found in joint fluid and lubricates and cushions the joints, allowing for smooth movement.

Pycnogenol® improves skin hydration and elasticity

Pycnogenol® was shown to increase skin elasticity and reduce skin fatigue by stimulation of the synthesis of new collagen and hyaluronic acid in the skin and inhibiting the activity of destructive enzymes (metalloproteinases 1,2 and 9) that break down collagen and elastin (8, 18, 20, 21). Pycnogenol® further protects skin proteins by selectively binding to elastin and collagen (21).

Clinical investigations of Pycnogenol® supplementation for 12 weeks revealed increased hyaluronic acid synthase levels within the skin by 44%, leading to improved skin hydration by 21% (20). In this study, Pycnogenol® was also shown to improve skin elasticity by 25% and decrease skin fatigue by 30%. In addition, Pycnogenol® increased the generation of collagen by 40%.

These beneficial effects of Pycnogenol® on the maintenance of an elastic and smooth skin have been confirmed in several clinical studies.

Pycnogenol® has beneficial effects on joint function

Pycnogenol® has been shown to act beneficially in patients with joint problems by downregulating pro-inflammatory markers and enzymes, that are responsible for destroying cartilage in joints specifically in the knee joint fluid (45, 46, 51-53). These results confirm previous findings on the anti-inflammatory activities of Pycnogenol® (17-19, 21).

In most cases, joint pain is due to damage to the articular cartilage. Hyaluronic acid contributes to the shock-absorbing abilities of cartilage. As Pycnogenol® significantly increased gene expression of hyaluronic acid synthase, this is helpful not only for skin but also for articular cartilage (20). Additionally, the abilities of Pycnogenol® to increase the synthesis of collagen and to protect collagen from degradation are crucial for joint health as collagen is an important component of articular cartilage. These results are backed up by the finding of a strong increase of the concentration of Pycnogenol®’s metabolites in the synovial fluid, surrounding articular cartilage in the joints in osteoarthritis patients (46, 54). This comprehensively explains how Pycnogenol® contributes to restoring health in damaged joints.

Pycnogenol® French pine bark extract is one of the most widely investigated natural supplements worldwide with convincing data for various fields of application, including heart health, skin care, cognitive function and allergy control. Pycnogenol® is a standardized complex mixture of many molecules and has shown beneficial efficacy on blood circulation, strong anti-inflammatory and antioxidant effects and impressive action on the integrity of tissues.

For further information on Pycnogenol® please visit www.pycnogenol.com .

Article written by Dr. Franziska Weichmann, Manager of Scientific Communications and Product Development at Horphag Research.

References

1. Rohdewald P, et al.: Basic Health Publications, Inc.; 2015. 178 p.

2. Horphag Research. Pycnogenol® 2023 [Available from: https://www.pycnogenol.com/.

3. Enseleit F, et al. Eur Heart J. 2012;33(13):1589-97.

4. Ryan J, et al. J Psychopharmacol. 2008;22(5):553-62.

5. Weyns A-S, et al. Journal of Functional Foods. 2022;97:105246.

6. Wilson D, et al. Phytother Res. 2010;24(8):1115-9.

7. Steigerwalt R, et al. J Ocul Pharmacol Ther. 2009;25(6):537-40.

8. Zhao H, et al. Skin Pharmacol Physiol. 2021:1-11.

9. Maia H, Jr., et al. Int J Womens Health. 2014;6:1019-22.

10. Kohama T, et al. J Reprod Med. 2013;58(1-2):39-46.

11. Chovanova Z, et al. Free Radic Res. 2006;40(9):1003-10.

12. D̆uračková Z, et al. Nutrition Research. 2003;23(9):1189-98.

13. Devaraj S, et al. Lipids. 2002;37(10):931-4.

14. Kolacek M, et al. Free Radic Res. 2013;47(8):624-34.

15. Yang HM, et al. Acta Obstet Gynecol Scand. 2007;86(8):978-85.

16. Errichi S, et al. Panminerva Med. 2011;53(3):65-70.

17. Canali R, et al. Int Immunopharmacol. 2009;9(10):1145-9.

18. Grimm T, et al. J Inflamm (Lond). 2006;3:1.

19. Schäfer A, et al. Biomed Pharmacother. 2005;60(1):5-9.

20. Marini A, et al. Skin Pharmacol Physiol. 2012;25(2):86-92.

21. Grimm T, et al. Free Radic Biol Med. 2004;36(6):811-22.

22. Fitzpatrick DF, et al. J Cardiovasc Pharmacol. 1998;32(4):509-15.

23. Nishioka K, et al. Hypertens Res. 2007;30(9):775-80.

24. Uhlenhut K, et al. Free Radic Biol Med. 2012;53(2):305-13.

25. Liu X, et al. Life Sci. 2004;74(7):855-62.

26. Zibadi S, et al. Nutr Res. 2008;28(5):315-20.

27. Hu S, et al. Int Angiol 2015;34(1):43-52.

28. Belcaro G, et al. Clin Appl Thromb Hemost. 2006;12(3):318-23.

29. Belcaro G, et al. Angiology. 2005;56(6):699-705.

30. Cesarone MR, et al. Angiology. 2006;57(4):431-6.

31. Wang S, et al. European Bulletin of Drug Research. 1999;7(2):19-25.

32. Araghi-Niknam M, et al. Integrative Medicine. 1999;2(2/3).

33. Pütter M, et al. Thrombosis Research 1999;55:155–61.

34. Cai C, et al. Health Science Reports. 2023;6(1).

35. Cesarone MR, et al. Minerva Cardioangiol. 2019;67(4):280-7.

36. Luzzi R, et al. Minerva Med 2014;105:245-54.

37. Grossi MG, et al. Panminerva Med. 2010;52(2):63-7.

38. Hosseini S, et al. Nutr Res. 2001;21(9):1251-60.

39. Stuard S, et al. Panminerva Med. 2010;52(2):27-32.

40. Schäfer A, et al. Diabetes Res Clin Pract. 2007;77(1):41-6.

41. Koch R. Phytother Res. 2002;16 Suppl 1:S1-5.

42. Trebaticky B, et al. Bratisl Med J. 2019;120(12):941 – 4.

43. Belcaro G, et al. Phytother Res. 2013;27(10):1572-8.

44. Zuo L, et al. International Journal of Molecular Sciences. 2019;20(18):4472.

45. Cisar P, et al. Phytother Res. 2008;22(8):1087-92.

46. Jessberger S, et al. BMC Complement Altern Med. 2017;17(1):537.

47. Kohama T, et al. J Reprod Med. 2007;52(8):703-8.

48. Maia H, Jr., et al. Int J Womens Health. 2013;6:35-9.

49. Belcaro G, et al. Panminerva Med. 2011;53(3):57-64.

50. Belcaro G, et al. Minerva medica. 2013;104(4):439-46.

51. Belcaro G, et al. Redox Rep. 2008;13(6):271-6.

52. Farid R, et al. Nutrition Research. 2007;27(11):692-7.

53. Belcaro G, et al. Phytother Res. 2008;22(4):518-23.

54. Mülek M, et al. Nutrients. 2017;9(5).

Daiya Foods Announces Strategic Leadership Appointment: Hajime Fujita as CEO

0

In a significant move underscoring its commitment to leadership excellence and strategic growth, Daiya Foods’ Board of Directors has proudly announced the appointment of Hajime Fujita as the company’s new Chief Executive Officer. This pivotal decision marks a new era for Daiya Foods as it continues to assert its dominance in the plant-based food industry, both in North America and on the global stage.

A Proven Leader with a Global Perspective

Hajime Fujita, a seasoned executive with over 17 years of extensive experience in global business and financial planning, is set to spearhead Daiya Foods’ operations. His expertise, particularly in the US and Asia-Pacific regions, positions him uniquely to drive the company’s ambitious growth plans. Fujita’s journey with Daiya began as a Director, following his instrumental role in facilitating the acquisition of Daiya by Otsuka Pharmaceuticals in 2017. His tenure at Otsuka Pharmaceuticals, culminating in the role of Vice President, Business Planning, has been marked by significant achievements, including his pivotal contribution to the development of Daiya’s state-of-the-art manufacturing facility in Burnaby, British Columbia.

Fujita’s Vision for Daiya

Reflecting on his appointment, Mr. Fujita expressed his enthusiasm for Daiya’s potential in revolutionizing the plant-based sector through innovative product development and aggressive marketing strategies. “Rejoining Daiya during this dynamic phase in the plant-based industry is exhilarating. I am eager to collaborate with our talented team to further elevate the Daiya brand and make a substantial impact in the market,” said Fujita.

Strategic Leadership Restructuring

Complementing Mr. Fujita’s appointment, Daiya’s Board has also announced strategic changes within the leadership team. Melanie Domer, previously Chief Marketing Officer, will transition to the role of Chief Commercial Officer, integrating marketing and sales functions. Concurrently, John Kelly, formerly VP of Consumer Marketing, steps into the role of Chief Marketing Officer. These changes are designed to streamline Daiya’s operations, enhancing consumer engagement and driving category growth.

Melanie Domer commented on her new role, “Integrating sales and marketing under one umbrella will enable Daiya to create more cohesive consumer experiences and strengthen our position in the plant-based food sector.” John Kelly added, “Leading Daiya’s marketing initiatives is a privilege. I am committed to propelling the brand to new heights and solidifying our status as a leader in the plant-based food industry in North America.”

Looking Ahead

With these strategic leadership appointments and organizational changes, Daiya Foods is poised to not only expand its market reach but also to redefine the plant-based food industry. Under the guidance of Hajime Fujita and the newly structured leadership team, Daiya is set to embark on a journey of innovation, growth, and unparalleled market leadership.

FDA Enforces Strict Compliance: Utah Dietary Supplement Firms Face Federal Action

0

FDA Takes Action Against Dietary Supplement Companies for Non-Compliance
In a landmark decision impacting the dietary supplement industry, the U.S. Food and Drug Administration (FDA) has taken decisive action against two Utah-based companies for non-compliance with federal health regulations. This move underscores the FDA’s commitment to safeguarding public health and ensuring adherence to the Federal Food, Drug, and Cosmetic Act.

Consent Decrees Issued to Evig LLC and Premium Production LLC
The U.S. District Court for the District of Utah, Central Division, has issued two consent decrees of permanent injunction against Evig LLC, headquartered in St. George, Utah, and its CEO, Douglas Lex Howard, as well as against Premium Production LLC, also based in St. George, Utah, and its Manager, Ryan Petersen.

 Marketing of Balance of Nature Products Under Scrutiny
These companies, known for distributing Balance of Nature products, have faced scrutiny for marketing these supplements with claims that categorize them as unapproved new drugs and misbranded drugs. Notably, the FDA has not endorsed Balance of Nature products for any medical use, despite the company’s assertions that they can diagnose, cure, mitigate, treat, or prevent various diseases, including cancer, heart disease, cirrhosis, diabetes, asthma, and even COVID-19.

Violations of Good Manufacturing Practices
A critical issue identified was Evig LLC’s violation of current good manufacturing practice (CGMP) requirements, leading to the categorization of its products as adulterated dietary supplements. Evig LLC has been distributing these products through major retailers like Amazon and Walmart, as well as through its website, www.balanceofnature.com.

Similarly, Premium Production LLC and Ryan Petersen have been found in violation of numerous CGMP requirements, particularly in establishing specifications for the identity, purity, strength, and composition of ingredients and finished products. This non-compliance has resulted in their products being deemed adulterated dietary supplements.

FDA’s Commitment to Public Health and Safety
Michael C. Rogers, the FDA’s Acting Associate Commissioner for Regulatory Affairs, emphasized the importance of this action. “This FDA action ensures that dietary supplements distributed to American consumers are appropriately labeled, lawfully manufactured, and prevents products that potentially put people’s health at risk with unproven claims to cure, treat or prevent a serious illness,” he stated. The FDA had previously warned both companies, but persistent violations of manufacturing requirements have led to a lack of public confidence in their products. The FDA remains committed to protecting U.S. public health by enforcing compliance with the law.

Historical Context and Ongoing Enforcement
In 2019, the FDA issued warning letters to both Evig LLC and Premium Production LLC following facility inspections that revealed CGMP violations. Despite these warnings and subsequent inspections, the firms failed to rectify the deviations and comply with FDA requirements, leading to the pursuit of injunctions against them.

Legal Implications and Future Compliance
Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Justice Department’s Civil Division, reiterated the necessity of FDA approval for products intended to treat or cure diseases. He stressed that dietary supplement makers must comply with federal health and safety requirements, and the Department will work closely with the FDA to halt the distribution of unapproved, adulterated, and misbranded dietary supplements.

The consent decrees prohibit Evig LLC and Premium Production LLC from distributing or manufacturing products until they comply with CGMP and labeling regulations. Both firms are required to hire CGMP experts, submit compliance documents, and receive FDA approval to resume operations. Additionally, Evig LLC must employ a labeling expert to ensure their products are no longer classified as new and/or misbranded drugs.

The U.S. Department of Justice filed these complaints on behalf of the FDA, marking a significant step in regulatory enforcement in the dietary supplement industry. This case serves as a reminder of the importance of compliance with federal regulations to ensure the safety and efficacy of dietary supplements in the market.

Important Recall Notice: Herbaland Gummy Vitamins Pose Health Risks

0

In a significant health alert, Herbaland Naturals Inc. has announced a recall of all Herbaland gummy vitamins and supplements sold in bulk. This recall is due to the potential serious health risks these products may pose, particularly to children and pregnant individuals.

These products, sold at various bulk, low- or zero-waste refillery stores across Canada, lack the necessary labeling, depriving consumers of critical information for safe consumption. This includes dosing instructions, ingredient lists, and safety warnings.

Affected products
Product NPN
Herbaland Biotin Beauty Gummy for Adults

Herbaland Hair Skin and Nails Gummy

Herbaland PURE BEAUTY Gummy for Adults

Good Gummies Beauty

80101367
Herbaland Calcium D3 Gummy for Kids

Herbaland Calcium plus Ds Gummies for Kids

80120325
Herbaland Calcium K2 D3 Gummy

Herbaland Calcium D3 K2 Gummies

Herbaland Calcium plus K2 D3 Gummies

80096991
Herbaland Calcium with Vitamin D3 Gummy for Kids

Herbaland Kids’ Gummy Calcium with Vitamin D3

Purever Canada Kids’ Gummy Calcium with Vitamin D3

80066501
Herbaland Classic Vitamin D3 400IU Gummy

Herbaland Kids’ 400IU Vitamin D3 Gummy

Herbaland Vitamin D3 400IU Gummy for Kids

Purever Canada Kids’ 400IU Vitamin D3 Gummy

Sunshine Nutrition Cool Gummies Vitamin D3 Gummies

80066489
Herbaland Immune Boost Gummies for Kids

Herbaland Immune Boost Gummy

Herbaland Immune Gummy for Kids/Adults

Herbaland Immune Plus Gummies for Adults

Herbaland Immune Plus Gummy

Herbaland Kids Immune Gummy

Good Gummies Immunity

80078758
Herbaland Kid’s Omega 3 Gummy with DHA and EPA

Purever Canada Kid’s Omega 3 Gummy with DHA and EPA

Sunshine Nutrition Cool Gummies Omega 3 with DHA/EPA

80076466
Herbaland Multivitamin Gummies for Adults

Herbaland Multivitamins & Minerals with Organic Fruits Gummy for Adults

Purever Canada Multivitamins & Minerals with Organic Fruits Gummy for Adults

Good Gummies Multivitamins

80074367
Herbaland Multivitamin Gummy for Kids 80089203
Herbaland Organic Fruit Vegetable and Fiber Gummy

Herbaland Organic Fruit Vegetable and Fiber Gummy for Adults/Kids

Herbaland Prebiotic Fruit, Veg & Fiber Gummy

Good Gummies Fruit, Veg & Fiber

Purever Canada Organic Fruit Vegetable And Fiber Gummy

Sunshine Nutrition Cool Gummies Fruit, Vegetable & Fiber Gummies

80072657
Herbaland Sleep Plus Gummy for Adults

Herbaland Simply Sleep Gummy for Adults

Herbaland Gummies Sweet Dreams

Herbaland Sleeping Beauty Gummy For Adults

80093743
Herbaland Sugar Free Prenatal Gummy

Herbaland Prenatal Gummy

80117248
Herbaland Gummies Glowing Beauty

Herbaland Vegan Collagen Booster Gummy for Adults

Good Gummies Healthy Skin

Squish + Herbaland Vegan Collagen Booster Gummy

80090622
Herbaland Gummies Vegan D3 & B12

Herbaland Vegan D3 + B12 Gummy for Adults

Herbaland Vegan Vitamins D3 & B12 Gummy

80071250
Herbaland Vegan Omega 3 Gummy Adult/Kids 80087674
Herbaland Vitamin C Gummy for Kids

Purever Canada Vitamin C Gummy for Kids

Sunshine Nutrition Cool Gummies Vitamin C Gummies

80078790
Herbaland Calm Gummy

Herbaland Calm Naturally Gummies for Adults

Herbaland Gummies Calm Naturally

Herbaland Magnesium Plus Gummy

Herbaland Zen Gummies

80105248
Herbaland Pre-workout Gummies for Adults 80096783

 

Why This Recall is Critical

The absence of proper labeling can lead to the misuse of these supplements, leading to health issues ranging from minor ailments like upset stomachs to severe reactions such as allergic responses or even birth defects in unborn children. Children and pregnant people are especially vulnerable due to their unique physiological needs and sensitivities.

The Confusion with Candy

Adding to the risk is the possibility of these gummies being mistaken for candy, increasing the likelihood of overconsumption, especially among children.

Health Canada’s Involvement

Health Canada is closely monitoring this recall and is committed to updating the public on any new health risks identified. The department is also working on enhancing the safety regulations for natural health products (NHPs).

What Should You Do?

Immediate Actions:
Cease the use of these bulk products and keep them out of children’s reach.

Disposal Instructions:
Follow local guidelines for hazardous waste disposal or return the products to a pharmacy.

Health Concerns:
Consult a healthcare professional if you have health concerns after using these products.

Contact Information:
For queries about this recall, contact Herbaland Naturals Inc. at 1-877-464-8669.

Report Side Effects:
Any health product-related side effects or complaints should be reported to Health Canada.

Purity Life Acquires Indigo Natural Foods Assets to Expand Distribution Network

0

 

 

Purity Life Expands Natural Health Products Distribution with Indigo Acquisition

Purity Life is thrilled to announce the strategic acquisition of Indigo Natural Foods Inc., a key player in Toronto’s natural health market since 1996. This acquisition not only broadens our portfolio with dozens of new brands but also fortifies our relationships with existing ones, signifying a major leap in our distribution capabilities.

 

Strategic Acquisition Marks a New Era for Purity Life and Indigo Partners

The addition of Indigo’s assets represents a new chapter for both companies. With this move, Purity Life reaffirms its commitment to the industry and continues to build upon a legacy of excellence in distributing Health and beauty, Supplements, and Dry Food products.

 

Purity Life Welcomes Indigo Personnel for a Seamless Business Transition

To maintain continuity and high standards of service, Purity Life is excited to welcome Melissa Schlegel and Emily Douglas from Indigo. Their expertise will be instrumental in ensuring that the transition honours the longstanding relationships with Indigo’s customers and vendors.

Purity Life’s President & CEO, Matthew James, highlights the significance of this transition, reflecting on the journey with John Anthony, a pioneer in the industry. John Anthony, Founder of Indigo, expresses his trust in Purity Life, acknowledging their shared history and strong focus on health food stores.

This transaction is more than a growth opportunity; it’s a reinforcement of our #EasyToDoBusinessWith philosophy. We’ve dedicated significant effort to ensure a smooth integration process that upholds the quality and service our partners expect.

As Purity Life moves forward, we are excited to strengthen our service offerings and continue providing the highest quality of care to our customers and vendors. Stay tuned for further updates on how this acquisition will positively impact our service and product range.

Discover more about Purity Life’s expanded distribution network and our dedication to quality in the natural health products industry on our website.

2023 National Summit on Indigenous Mental Wellness Concludes in Ottawa

0

A Week of Reflection and Progress

As we stand a week removed from the conclusion of the 2023 National Summit on Indigenous Mental Wellness, IHR Magazine takes a moment to reflect on the significant strides made during this pivotal gathering in Ottawa. Indigenous leaders, community advocates, and government officials came together to forge new paths in addressing the mental health challenges faced by Indigenous communities across Canada.

Chief John Rampanen from Ahousaht First Nation and other distinguished panelists discuss a partnership focused on health and wellness.

Government Commitment and Indigenous Leadership

Ministers Engage in Meaningful Dialogue

The Summit, which took place last week, was graced by the presence of the Minister of Indigenous Services, Patty Hajdu, and the Minister of Mental Health and Addictions and Associate Minister of Health, Ya’ara Saks. Their participation underscored the Government of Canada’s dedication to supporting Indigenous-led mental wellness initiatives.

Embracing Traditional Practices and Distinctions-Based Approaches

The Government of Canada has been clear in its recognition of the importance of distinctions-based, Indigenous-led approaches to mental wellness. Since 2018, there has been a concerted effort to adapt programs to incorporate traditional Indigenous healing practices, acknowledging the deep-seated impacts of colonization and social inequities.

Minister Patty Hajdu shares opening remarks at the 2023 National Summit on Indigenous Mental Wellness.

Summit Highlights and Innovations

Prioritizing Crisis Support and Youth

Over two days, the Summit focused on crisis support for communities and the mental wellness of Indigenous youth and children. Workshops and sessions delved into gender-based initiatives, support for the mental wellness workforce, land-based approaches, and youth mental wellness.

Showcasing Community Strength and Youth Initiatives

The event highlighted a plethora of youth-led projects and community-based initiatives, showcasing the resilience and innovation present across the nation. Notable were the programs tailored for 2SLGBTQIA+ Indigenous youth, on-the-land programming, and virtual support systems.

Voices of Leadership

Minister Patty Hajdu on Holistic Connections

“For centuries, Indigenous Peoples have known that wellness and health depended on holistic connections and relationships with each other, and with culture. Western systems of care have often not worked to bring relief and healing for Indigenous Peoples, leading to great suffering, loss and difficult cycles of hope followed by despair. Bringing Indigenous Peoples together to share the approaches to healing is powerful and necessary to see stronger people and communities.”

Minister Ya’ara Saks on Partnership and Support

“Intergenerational trauma, the effects of colonization, the residential school system, the Sixties Scoop, poverty and many other factors contribute to Indigenous peoples having experienced higher rates of mental health and substance use issues. During this summit, we had the opportunity to hear from Indigenous organizations who have been doing incredible work, with their culturally safe approaches to mental well-being, including land-based approaches to treatment and healing. We are committed to working in partnership with them, Indigenous leaders, communities and others, to promote compassionate approaches to mental wellness that put people first.”

Quick Facts and Governmental Support

Strategic Frameworks and Investments

Indigenous Services Canada (ISC) aligns its work with key documents developed by Indigenous partners, such as The First Nations Mental Wellness Continuum Framework and The National Inuit Suicide Prevention Strategy. The government’s financial commitment has been substantial, with ISC doubling its spending to support Indigenous mental wellness since 2015, reaching approximately $650 million in 2023-24.

Looking Ahead

As the dust settles on the 2023 National Summit on Indigenous Mental Wellness, the path forward is illuminated by the shared knowledge and collaborative spirit demonstrated during this event. IHR Magazine remains committed to reporting on these essential developments, as we collectively work towards a future where mental wellness is accessible and culturally resonant for all Indigenous Peoples.

United Natural Foods Appoints Andre Persaud as President and CEO of Retail

0

A New Era of Leadership for UNFI’s Retail Division

United Natural Foods, Inc. (UNFI) has officially announced the appointment of Andre Persaud as President and Chief Executive Officer of Retail, a strategic move that took effect on November 6, 2023. This appointment marks a significant milestone in UNFI’s journey to strengthen its leadership team and enhance its retail operations.

Andre Persaud: A Profile in Retail Excellence

Andre Persaud is a seasoned professional with nearly 30 years of retail experience, particularly noted for his leadership roles over the past two decades. His career spans across various senior positions with notable companies in the food and pharmacy sectors, demonstrating a robust track record of success.

Leadership Across the Aisles

Persaud’s journey in retail leadership has been diverse and impactful:

  • Chief Retail Officer of Rite Aid: Steering the $17 billion drugstore business.
  • Executive Consultant at Wakefern Foods/ShopRite: Providing strategic executive consultancy.
  • Executive Vice President Retail at Shopko Stores: Overseeing retail operations.
  • Senior Vice President of Store Operations at Burlington: Managing store operations.
  • Senior Vice President at Loblaw Companies Ltd: Leading at one of Canada’s largest food retailers.
  • Progressive Leadership Roles: At Shoppers Drug Mart and Wal-Mart Canada.

Most recently, Persaud has been a senior advisor with Alvarez and Marsal Consumer and Retail Group, offering C-level expertise to clients. His advisory roles extend to Pharmacity, a leading pharmacy chain in Vietnam.

Industry Recognition and Academic Foundations

Andre Persaud’s contributions to the retail industry have not gone unnoticed. He has been lauded as one of the top fifty retail executives in North America by Mass Market Retailers, recognized as a top retail power player by Business Insider magazine, and honored by the National Diversity Council for leadership excellence. His academic credentials are equally impressive, holding both a bachelor’s and master’s degree from the State University of New York at Buffalo.

UNFI’s Strategic Vision with Persaud at the Helm

With Persaud’s appointment, UNFI is poised to enhance its retail operations under the banners of CUB and Shoppers Food Warehouse. His role on the senior leadership team, reporting directly to Sandy Douglas, UNFI’s CEO and President, signals a clear directive for growth and operational excellence.

Looking Forward

“Andre is a proven leader with a demonstrated track record of success across a range of retail organizations,” said Douglas. “We are excited for Andre to join our team and look forward to the positive contributions he will bring to the Company in this leadership position.”

As UNFI continues to navigate the competitive landscape of the food and pharmacy retail sector, Andre Persaud’s leadership is expected to be a driving force in the company’s continued success and innovation.

Stay tuned to IHR Magazine for more updates on how Andre Persaud’s leadership will shape the future of UNFI’s retail strategy.

Movember Canada: A Hairy Ribbon for Men’s Health

0

Uniting for a Cause: The 17th Annual Movember Campaign

A week ago, the landscape of men’s health advocacy in Canada was reinvigorated as the Movember campaign, the leading global men’s health charity, launched its 17th annual drive. This initiative sees men nationwide, affectionately known as “Mo Bros,” and their supportive “Mo Sisters,” come together to sport moustaches as a sign of solidarity and commitment to men’s health.

The Stark Reality: Men’s Health by the Numbers

The statistics are a sobering reminder of the importance of this cause. In Canada, prostate cancer will affect 1 in 8 men during their lifetime, while testicular cancer remains the most common cancer among young men. Moreover, a staggering 75% of suicides are committed by men.

How to Participate: More Than Just Growing a Moustache

Movember is synonymous with the growth of moustaches, but participation extends beyond facial hair. For those unable to grow a moustache or who prefer other means of involvement, Movember offers diverse ways to engage:

GROW: The Moustache Movement

Starting clean-shaven, men are encouraged to grow and maintain a moustache throughout the month, symbolizing their advocacy and sparking conversations about men’s health.

MOVE: The 60km Challenge

Participants commit to moving 60km over the month, representing the 60 men lost to suicide every hour worldwide. This can be through any form of physical activity.

HOST: Creating Mo-ments

Movember advocates can host events to gather friends and community members to have fun and fundraise for the cause.

MO YOUR OWN WAY: Personal Challenges

Individuals are also encouraged to set personal challenges or goals, whether they’re related to fitness, wellness, or personal development.

The Impact of Movember Funds

Movember’s efforts are more than symbolic. The funds raised have led to significant advancements in medical science and the reshaping of health services for men. Contributions have supported the development of life-extending therapies, innovative cancer detection methods, and crucial mental health initiatives.

Canadian Initiatives Making Global Strides

Movember’s impact in Canada has been profound, with substantial investments in research and support programs:

  • In September 2023, Movember announced up to $5.8 million CAD in new research grants.
  • Continuing through 2024, Movember is funding programs for veterans and first responders’ mental health, with a $1.6M investment.
  • A partnership with Pringles in Canada has been formed to foster discussions on men’s mental health, with Pringles contributing $125,000 CAD to the cause.

Join the Movement

Movember’s work is ongoing and extends beyond the month-long campaign. For more information or to become part of the Movember movement, visit www.movember.com.

Movember is not just a campaign; it’s a movement towards a future where the men in our lives live happier, healthier, and longer lives. Join us in making a difference.